TA

TACIT THERAPEUTICS

2 known investors

tacittx.com ↗

Tacit develops RNA repair technology called Splicing-Directed Repair, which uses naturally-occurring biological systems to fix genetic mutations as an alternative to conventional gene editing. The company aims to build a platform for treating a range of genetic diseases.

Investors · 2

EI

Eisai Innovation, Inc.San Francisco

KD

KdT VenturesreportedAustin · $500K – $3M